Founded Date: 2006
Total Funding: $102.5M
Investor Type: Company
Employee Number: 51-100
Investment Stage: N/A
Funding Status: N/A
Number Of Exists: Venture - Series Unknown
Technology: Cancer
Last Funding Type: Venture - Series Unknown
Investors Number: 7
Industry: Gene Therapy
Headquarters: Abingdon, Oxfordshire, United Kingdom
Estimated Revenue: $10M to $50M